NewsRoom Articles - Page 55 of 225

MondayMar 11, 2024 10:45 am

Rheumatoid Arthritis Patients Face Heightened Risk of Depression, Study Finds

Recently published data shows that rheumatoid arthritis patients have a heightened risk for developing depression. This study is the first to investigate the link between rheumatoid arthritis and the risk of developing depression. The researchers’ objective was to examine the effect of anticyclic citrullinated peptide and rheumatoid factor antibodies on depression in patients with rheumatoid arthritis and find data on the effect of DMARD prescriptions on rheumatoid arthritis-associated depression. These antibodies serve as markers of illness severity and offer insights into the risk of comorbidity. On the other hand, DMARD prescriptions are often given with other drugs such as NSAIDs…

MondayMar 11, 2024 10:30 am

Astiva Health Inc. — Pioneering a New Era in Aging Healthcare

Astiva Health is revolutionizing patient involvement in healthcare, particularly for the aging population Beyond offering healthcare services, Astiva is dedicated to creating a supportive health community With patients at the center, Astiva Health is transforming aging healthcare into a proactive, participatory experience The United States is in the midst of a global demographic shift toward an aging population, with the U.S. Census Bureau projecting that by 2034, adults aged 65 and older will outnumber children under the age of 18 for the first time in U.S. history (https://ibn.fm/yGoyH). With this shift, the demand for a more holistic approach to healthcare…

FridayMar 08, 2024 11:00 am

Rising Cases of Autism in UK Raise Concerns

Decades ago, researchers believed that autism disoder affected one in every 2,500 kids. Today, it is estimated that one in 36 kids have the disorder. Autism spectrum disorder is a developmental disorder that affects how an individual interacts with other people, behaves, communicates and learns. While this disorder can be diagnosed at any age, symptoms often appear in the first two years of life. Research has found that between 1998 and 2018, there has been a more than 780% increase in the number of autism cases in the United Kingdom. This significant increase is partly because of a deeper understanding…

FridayMar 08, 2024 9:45 am

PaxMedica Inc. (NASDAQ: PXMD) Pursues Autism Treatment as Diagnostic App Shows Promise to Effective ASD Diagnosis

One in 36 children are diagnosed with autism spectrum disorder (“ASD”) – with ASD four times more common among boys than girls The SenseToKnow app accurately predicted eventual autism diagnoses in a group of 475 children – according to the study, performance was similar across sex, race, and ethnicity PaxMedica is leveraging historical data on the drug suramin to fund trials aimed at treating Autism Spectrum Disorder and Fragile X-Associated Tremor/Ataxia Syndrome According to the CDC, about 1 in 36 children are diagnosed with autism spectrum disorder (“ASD”) – with ASD four times more common among boys than girls (https://ibn.fm/06kly).…

WednesdayMar 06, 2024 10:30 am

Despite Slowing Growth, eCommerce Sales Reach Record Level in US

Latest figures from the Department of Commerce show that the slowest growth in e-commerce sales was recorded during the last quarter of 2023. This is in comparison to the previous quarter and 2022’s last quarter. In the third quarter of 2023, growth in ecommerce sales stood at 7.8% while that of 2022’s last quarter was 7.7%. On a positive note, Q4 sales in the United States hit $324.8 billion, according to an analysis conducted by Digital Commerce 360. This figure represented more than 7% growth when compared with figures from the last quarter of 2022. Data from the department shows…

TuesdayMar 05, 2024 9:45 am

Sigyn Therapeutics Inc. (SIGY) Therapeutic Candidates to Overcome Limitations in Healthcare

Sigyn Therapeutics is developing four medical device candidates – Sigyn Therapy(TM), ChemoPrep(TM), ChemoPure(TM), and ImmunePrep(TM) – designed to overcome current therapeutic limitations in healthcare Sigyn Therapy(TM), the company’s lead product candidate, is a single-use disposable device to treat life-threatening inflammatory conditions that are beyond the reach of drugs ChemoPrep(TM) is designed to optimize the tumor-site delivery of chemotherapy, while ChemoPure(TM) intends to reduce the toxicity of chemotherapy by sweeping off-target chemotherapy out of the bloodstream ImmunePrep(TM) is designed to reduce the presence of circulating drug decoys that interfere with the delivery of immunotherapeutic antibodies to treat cancer Medical technology company Sigyn…

MondayMar 04, 2024 11:00 am

Study Links Parkinson’s Onset in Rocky Mountain Area to Agricultural Pesticides

Preliminary research has found that herbicides and pesticides used in farming may be associated with Parkinson’s disease. For their research, the investigators reviewed records from more than 20 million individuals obtained from Medicare. The objective of the researchers was to calculate the rate of Parkinson’s disease for different regions in the country. They also examined possible links between the use of more than 60 pesticides and rates of Parkinson’s disease. The author of the study, Brittany Krzyzanowski, explained that the team of investigators utilized geographic techniques to study the disorder’s rates then compared their findings to regional levels of herbicide…

MondayMar 04, 2024 10:30 am

Astiva Health Inc. CEO Featured Podcast Guest, Talks Commitment to Help Patients Enjoy ‘Active, Healthy and Meaningful’ Lives

In addition to providing full medical-care prescription drugs, Astiva focuses on providing rich supplemental benefits to enrollees CEO explains that “effective healthcare hinges largely on patient involvement” Astiva’s recent expansion is a crucial step in extending invaluable benefits and commitment to quality healthcare to a growing, diverse population Astiva Health CEO Dr. Tri Nguyen was the featured guest in a recent Bell2Bell Podcast release (https://ibn.fm/0Rufk). During the podcast, Nguyen talked provided an in-depth look at how Astiva Health is reshaping healthcare delivery, including an overview of the company’s commitment to patient involvement in healthcare and highlights the company’s innovative strategies in offering comprehensive…

FridayMar 01, 2024 11:30 am

A Comparison Between ALS, Parkinson’s Disease

Parkinson’s disease and amyotrophic lateral sclerosis (ALS) are conditions that affect an individual’s nervous system and brain. Both conditions also cause tremors during the early stages, which can affect an individual’s movement. Despite their similarities, however, the conditions require different treatments to manage their symptoms. Below, we look at the similarities and differences between ALS and Parkinson’s disease. What is Parkinson’s disease? This condition destroys cells in the basal ganglia, which makes it hard for individuals to control their movements. Data from the Parkinson’s Foundation shows that about 90,000 individuals are diagnosed with this condition annually in America. This condition’s…

WednesdayFeb 28, 2024 9:45 am

Siteman Cancer Center Starts Offering Novel Cell-Based Immunotherapy Against Melanoma

Patients with melanoma may soon be able to access a new immunotherapy that was recently approved by the U.S. Food and Drug Administration (FDA). The cell-based treatment, which was developed by Iovance Therapeutics, will first be administered by physicians at the Siteman Cancer Center in Washington University before it can be commercialized under the name Amtagvi. The tumor-infiltrating lymphocyte immunotherapy has been designed for the treatment of metastatic melanoma, which is a skin cancer that has spread to other parts of the body. The treatment, called lifileucel, has been designed specifically for patients suffering from this particular cancer whose tumor…